Carmot

Developer of disease-modifying therapies to treat metabolic diseases

placeBerkeley, California, United States calendar_todayFounded 2008 groups50 employees language carmot.us

Registered entities

Investor mix

19 investors on record; lead investors include Deep Track Capital, Horizons Ventures, The Column Group, Amgen; 1 has since exited.

Investor typeCountShare
Venture capital737%
Private equity15%
Angel & family office15%
Bank & private debt15%
Other / undisclosed947%
Coming soon